What LABMaiTE does

LABMaiTE GmbH is a privately held German AI company founded in 2021 and headquartered in Freiburg (Türkheimerstraße 4a, HRB 725466) that builds AI and automation software for two adjacent life-science verticals: cancer research and bioprocess technology. The company was spun out of a collaboration between BioThera Roland Mertelsmann Foundation, the University of Freiburg, and the University Hospital Freiburg, and operates with a 1-10 person team of biologists, bioprocess engineers and machine learning researchers.

The company's product surface is organized around two integrated technology stacks. The first is a computer-vision-based image analysis platform that extracts cell count, viability, confluency, tracking, and membrane roughness features from label-free microscopic images and is positioned for cancer research and neurodegenerative-disease drug screening. The second is the AMLAMaiTE bioprocess optimization system, which combines advanced probabilistic models with a fully automated microbioreactor to determine optimal culture conditions and has been shown to increase biomass output by up to 30% versus traditional Design of Experiments approaches. Both stacks are protected by granted patents and are being extended into CAR T-cell production optimization through the BMBF-funded iCARus project with Hochschule Kempten.

LABMaiTE monetizes through custom AI solutions and managed bioprocess services sold via a sales-led, enterprise-targeted go-to-market motion that relies on direct engagement, 'Request a Demo' CTAs, and presence at major industry events such as ACHEMA 2024, MEDICA 2023, and the BioProScale Symposium 2024. To date, the only disclosed funding is approximately EUR 480,000 in non-dilutive BMBF grant money spread over three years for the iCARus project; no equity financing rounds, named end customers, or revenue figures have been disclosed.

Name

LABMaiTE

Legal name

Labmaite GmbH

Website

https://labmaite.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

LABMaiTE GmbH is a Freiburg-based AI company that builds computer-vision image analysis for cancer research and probabilistic-model bioprocess optimization (AMLAMaiTE) for biomanufacturing and precision fermentation clients.

Ownership category

akta.pro rank

Product category

Biotechnology AI Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (54151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Lab Automation, Instrument Control & Workflow Orchestration Software (HLAGAJAG)

akta.pro secondary industries

Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)

Keywords

• AI image analysis
• Bioprocess optimization
• Cell characterization software
• Media optimization
• Custom research automation

Headquarters

HQ city

Freiburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Custom AI Solutions and Services: LABMaiTE offers customized data analysis, data insights and smart experimental design services. They process client experimental data to deliver optimized conditions for maximum production, operating as a seamless extension of the client's existing process.
2. AMLAMaiTE Bioprocess System: Tailored bioprocess solutions using their proprietary AMLAMaiTE system for media optimization in biomanufacturing and precision fermentation applications.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

LABMaiTE develops AI-powered software and automation solutions for cancer research and bioprocess technology. Its products include the AMLAMaiTE system for media optimization using probabilistic models (demonstrating up to 30% biomass increase over DoE methods) and computer-vision-based AI image analysis for cell characterization. The company also delivers tailored automation and custom AI analytics services as a seamless extension of client laboratory workflows.

Product overview

LABMaiTE offers a unified AI and automation solutions platform comprising two main product areas: (1) AI Image Analysis and Cell Characterization modules for cancer research, providing computer vision-based analysis of microscopic images with cell count, viability, confluency, and tracking capabilities, and (2) the AMLAMaiTE system for bioprocess media optimization using advanced Probabilistic Models that outperform traditional DoE methods. The company also provides customized automation solutions as add-on modules. All products share core AI/ML technology for processing optical data and images, with the AMLAMaiTE system leveraging the same ML foundation for growth optimization. LABMaiTE's patented technology is fully-automated and AI-based, designed to save time and money across the research process.

Differentiator

Problem solved

Functional benefit

Brands

• AMLAMaiTE: AI-powered bioprocess media optimization system using advanced Probabilistic Models to rapidly determine optimal culture conditions, outperforming traditional Design of Experiments (DoE) methods. The system achieves up to 30% increase in biomass output compared to industry standards.

Products and services

• AI Image Analysis Computer vision software that analyzes microscopic images to extract hidden insights beyond basic features for cancer research and biology laboratories. Capabilities include cell count, cell viability, cell confluency, cell tracking, membrane roughness, and custom analyses; the AI model distinguishes active and inactive cells, matching human researchers and detecting cells that traditional methods miss. Designed for research institutions working on drug screening and neurodegenerative disease research.
• AMLAMaiTE Bioprocess Optimization System State-of-the-art bioprocess media optimization system using advanced Probabilistic Models to rapidly determine optimal culture conditions. Outperforms traditional Design of Experiments (DoE) methods and achieves up to 30% increase in biomass output while reducing time and cost. Includes fully automated microbioreactor capabilities with real-time monitoring for biomanufacturing and precision fermentation customers.
• Cell Characterization AI-powered cell analysis technology that accurately distinguishes active and inactive cells, matching human researchers and detecting cells that traditional methods miss. Designed to enhance drug screening for neurodegenerative diseases including Alzheimer's, multiple sclerosis, and Parkinson's for cancer research and biology laboratories.
• Customized AI Data Analysis and Smart Experimental Design Services Professional services offering in which LABMaiTE processes client experimental data, delivers data insights and designs smart experiments to optimize culture conditions for maximum production. Operates as a managed/extension service for biomanufacturing clients using the AMLAMaiTE platform and underlying probabilistic models.

Quantifiable outcome

• Up to 30% increase in biomass output compared to industry standards (DoE) in bacteria growth optimization with 8 media components
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Hochschule Kempten (Institut für Produktion und Informatik)coreStrategic or Co-development Partner · 1 March 2024LABMaiTE teams up with Prof. Frieder Heieck for BMBF-funded iCARus project focused on CAR T-cell production optimization. Project funded through KMU-Innovativ program with approximately €480,000 over 3 years.
• Hochschule München (University of Applied Sciences)coreStrategic or Co-development Partner · 1 December 2023Collaborated on the AMLAMO project which wrapped up at end of 2023. Dr. Ing. Frédéric Lapierre showcased breakthrough results at BioProScale Symposium 2024. Prof. Dr. Robert Huber from Hochschule München serves on the advisory board.
• BioThera Roland Mertelsmann FoundationcoreStrategic or Co-development PartnerFounding partner of LABMaiTE alongside University of Freiburg and University Hospital Freiburg. Ensures commitment to excellence and guides the company to real problems to solve.
• University of FreiburgcoreStrategic or Co-development PartnerFounding academic partner of LABMaiTE alongside BioThera Roland Mertelsmann Foundation and University Hospital Freiburg. Contributed to the visionary collaborative project that originated LABMaiTE.
• University Hospital FreiburgcoreStrategic or Co-development PartnerFounding partner alongside BioThera Roland Mertelsmann Foundation and University of Freiburg. Ensures LABMaiTE's commitment to excellence in medical and biological research applications.
• BadenCampusminorStrategic or Co-development PartnerPartner organization supporting LABMaiTE's ecosystem and innovation initiatives.
• Start-Up-BW-AcceleratorminorStrategic or Co-development PartnerAccelerator program partner supporting LABMaiTE's growth and development as a startup in Baden-Württemberg.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• TetraScience: TetraScience is a large SaaS platform that industrializes scientific data and applies AI to lab and process data across biopharma. Comparable as an adjacent enterprise AI/data platform for life science R&D, overlapping with LABMaiTE's analytics and workflow-orchestration layer.
• Sartorius AG: Sartorius is a major bioprocess equipment and automation supplier serving cell therapy, vaccine, and biologics manufacturers. Comparable as the dominant incumbent in the bioprocess automation space where LABMaiTE's AMLAMaiTE operates, including overlap with CAR T-cell manufacturing customers.
• Yokogawa Electric (Bio): Yokogawa provides process automation, control systems, and bioreactor solutions for biopharma and industrial fermentation. Comparable as an incumbent in bioprocess process control where LABMaiTE's optimization and automation solutions are targeted.

Direct peers

• Culture Biosciences: Culture Biosciences offers cloud-based bioprocess development with ML-driven analysis for fermentation and cell culture optimization. Highly comparable to LABMaiTE's AMLAMaiTE system in applying probabilistic/ML models to bioprocess media optimization and scale-up.
• Synthace: Synthace builds a cloud biology platform that automates experimental design, execution, and data analysis for life science R&D. Directly comparable to LABMaiTE's mission of AI-driven workflow automation across cancer research and bioprocess experiments.

Emerging players

• Insitro: Insitro applies machine learning to biological data and combines high-throughput experimental biology with computational models. Comparable in using AI to accelerate biology and drug-discovery workflows, with overlap in cell imaging and bioprocess optimization themes.
• Bota Biosciences: Bota Biosciences applies ML-driven bioprocess tools to protein engineering and biomanufacturing optimization. Comparable as a peer emerging player building AI for bioprocess and fermentation, overlapping with LABMaiTE's AMLAMaiTE commercialization and precision fermentation customer base.
• Recursion Pharmaceuticals: Recursion uses high-content imaging combined with ML models to characterize cellular phenotypes for drug discovery. Directly comparable in computer vision-driven cell image analysis at scale, overlapping with LABMaiTE's AI image analysis and neurodegenerative disease research use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/labmaite

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LABMaiTE